<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    aim
   </journal-id>
   <journal-title-group>
    <journal-title>
     Advances in Microbiology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2165-3402
   </issn>
   <issn publication-format="print">
    2165-3410
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/aim.2025.159036
   </article-id>
   <article-id pub-id-type="publisher-id">
    aim-146045
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Tracking Antimicrobial Resistance in Environmental Waters: Risks, Routes, and Regulatory Needs
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Komal
      </surname>
      <given-names>
       Kaur
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Angela
      </surname>
      <given-names>
       Hodges
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Samina
      </surname>
      <given-names>
       Akbar
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aWood College of Osteopathic Medicine, Marian University, Indianapolis, USA
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     04
    </day> 
    <month>
     09
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    09
   </issue>
   <fpage>
    559
   </fpage>
   <lpage>
    582
   </lpage>
   <history>
    <date date-type="received">
     <day>
      11,
     </day>
     <month>
      June
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      23,
     </day>
     <month>
      June
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      23,
     </day>
     <month>
      September
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Background:</b> Antimicrobial resistance (AMR) in gram-negative bacteria represents a growing global health threat, increasingly fueled by environmental factors. Wastewater, agricultural runoff, aquaculture, and pharmaceutical discharge contribute to the release of antibiotic residues, resistant bacteria, and resistance genes into ecosystems. 
    <b>Objective:</b> This literature review explores the environmental persistence and dissemination of antibiotic resistance, focusing on the mechanisms by which multidrug-resistant (MDR) genes are maintained and transferred—particularly through water sources—and highlights emerging mitigation strategies and regulatory challenges. 
    <b>Key Findings:</b> Gram-negative bacteria such as Salmonella enterica and ESKAPE pathogens exhibit intrinsic and acquired resistance mechanisms, including efflux pumps and mobile genetic elements. Environmental reservoirs, especially wastewater treatment plants, facilitate horizontal gene transfer between pathogenic and non-pathogenic bacteria. Agricultural practices, antibiotic overuse, and inadequate waste management further exacerbate the spread. While ozone treatment, membrane bioreactor systems, bacteriophage therapy, and efflux pump inhibitors show promise in reducing AMR load, widespread implementation remains limited. Policy efforts—at federal, state, and international levels—lack consistency and enforcement, particularly regarding environmental discharge and regulation of antibiotic residues. 
    <b>Conclusion:</b> Environmental AMR, particularly via water systems, poses a substantial public health risk. A coordinated One Health approach, incorporating policy reform, technological advancements, and cross-sector collaboration, is essential to address AMR at its environmental source and mitigate its global spread.
   </abstract>
   <kwd-group> 
    <kwd>
     Antimicrobial Resistance
    </kwd> 
    <kwd>
      Gram-Negative Bacteria
    </kwd> 
    <kwd>
      Wastewater Treatment
    </kwd> 
    <kwd>
      Multidrug Resistance
    </kwd> 
    <kwd>
      Environmental Health
    </kwd> 
    <kwd>
      Salmonella enterica
    </kwd> 
    <kwd>
      Horizontal Gene Transfer
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <sec id="s1_1">
    <title>1.1. The Importance of Antibiotic Resistance in Gram Negative Bacteria</title>
    <p>Antimicrobial resistance (AMR) occurs when bacteria and other organisms acquire resistance mechanisms, <xref ref-type="bibr" rid="scirp.146045-1">
      [1]
     </xref> rendering antibiotics ineffective and making infections more difficult to treat <xref ref-type="bibr" rid="scirp.146045-1">
      [1]
     </xref>. AMR is a growing concern in clinical applications, with several pathogens developing resistance to multiple classes of antimicrobials. While previous reviews have focused on the mechanism of antibiotic resistance and its spread, especially in healthcare settings <xref ref-type="bibr" rid="scirp.146045-2">
      [2]
     </xref>-<xref ref-type="bibr" rid="scirp.146045-5">
      [5]
     </xref>, less research has been conducted on the maintenance of antibiotic resistance in the environmental settings.</p>
    <p>Compared to gram-positive bacteria, gram-negative bacteria demonstrate greater resistance to antibiotics and chemotherapeutic agents <xref ref-type="bibr" rid="scirp.146045-6">
      [6]
     </xref>. This can be attributed to their outer membrane, which limits the penetration of hydrophilic solutes, as well as the low fluidity of the lipopolysaccharide leaflet <xref ref-type="bibr" rid="scirp.146045-6">
      [6]
     </xref>. Additionally, these bacteria possess multiple drug efflux pumps that further contribute to their resistance capability <xref ref-type="bibr" rid="scirp.146045-6">
      [6]
     </xref>.</p>
    <p>A paper by Nikaido et al. (1998) <xref ref-type="bibr" rid="scirp.146045-6">
      [6]
     </xref> explains the function of these efflux pumps. Spanning both the inner and outer membranes of gram-negative bacteria, these pumps are powered by the proton-motive force, allowing them to expel a wide range of substances, including detergents, dyes, and antibiotics. They can also eliminate compounds such as beta-lactams, which typically have difficulty crossing the cytoplasmic membrane. Overexpression of these efflux pumps can significantly increase the minimum inhibitory concentrations (MICs) of antibiotics, contributing to the high resistance observed in gram-negative bacteria.</p>
    <p>This literature review aims to explore and attempts to answer how we can prevent pathogenic bacteria from passing multidrug resistant (MDR) genes to non-pathogenic bacteria in the environment by analyzing current information on gram-negative AMR in water sources.</p>
   </sec>
   <sec id="s1_2">
    <title>
     <xref ref-type="bibr" rid="scirp.146045-"></xref>1.2. Environmental Antibiotic Resistance</title>
    <p>The environment can become contaminated with antibiotics due to human and animal waste, pesticide use, pharmaceutical manufacturing wastage, and aquaculture <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. This is a major problem since these factors contribute to the spread of resistance among human populations <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>.</p>
    <p>Firstly, human waste contains traces of antibiotics <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. Unfortunately, wastewater treatment plants (WWTPs) are unable to remove all antibiotic residues and resistant genes <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. This is especially seen in wastewater from hospitals where patients are prescribed antibiotics and antifungals <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. A study by Berglund et al. (2023) investigated the emergence of mobile antibiotic resistance genes (ARGs) in wastewater environments <xref ref-type="bibr" rid="scirp.146045-8">
      [8]
     </xref>. They analyzed 22 bacterial species and determined the taxonomic origins of mobile ARGs based on previous research. The results showed that these species originated from wastewaters and human stool. The researchers focused on Mobilizing Insertion Sequence Elements (MISE) and their presence in the genome of the origin species. They examined complete genomes and metagenomic data to determine the environments where MISE are abundant. The findings revealed that MISE are present in untreated hospital effluent, wastewater treatment plant influent, and poultry feces <xref ref-type="bibr" rid="scirp.146045-8">
      [8]
     </xref>. Additionally, the study demonstrated that origin species carrying ARGs are more commonly observed in wastewaters and contaminated water/sediments, which may be linked to human feces <xref ref-type="bibr" rid="scirp.146045-8">
      [8]
     </xref>. The authors suggest that the mobilization of ARGs in human and animal microbiota occurs as a response to the selective pressure of antibiotics, given the connection between these species and infections <xref ref-type="bibr" rid="scirp.146045-8">
      [8]
     </xref>.</p>
    <p>Secondly, antibiotics used in livestock production, ultimately lead to contamination of soil and water sources <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. The use of untreated animal manure as fertilizer can also contribute to the spread of resistant bacteria in the environment <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. In the US, over 25 million pounds of antimicrobials are used annually in food-animal production, with approximately 13.5 million pounds of antibiotics being excreted in animal fecal waste each year <xref ref-type="bibr" rid="scirp.146045-9">
      [9]
     </xref>. These waste products containing antibiotics can enter the environment through various pathways such as manure, soil, runoff, or by being discharged as wastewater effluent into surface water and sediment <xref ref-type="bibr" rid="scirp.146045-9">
      [9]
     </xref>. In a paper by Williams et al. (2016) where the characterization of AMR among aquatic environments is reviewed <xref ref-type="bibr" rid="scirp.146045-10">
      [10]
     </xref>, they determined that surface water from which drinking water originates, is the discharge point for wastewater as well as runoff from animal farms <xref ref-type="bibr" rid="scirp.146045-10">
      [10]
     </xref>. This causes the spread of AMR between humans and animals <xref ref-type="bibr" rid="scirp.146045-10">
      [10]
     </xref>. In this article, studies discussing AMR in surface and recreational waters, municipal wastewater, healthcare-associated wastewater, airplane wastewater, industrial wastewater, farm animal wastewater, and aquaculture were reviewed. It also explored treatment technologies such as disinfection, activated sludge digestion, sludge composting, swine vermicomposting, fertilization, ionic liquid, and drinking water treatment as potential ways to prevent dissemination of AMR into the environment.</p>
    <p>Additionally, the use of pesticides in agriculture to mitigate crop diseases leads to the contamination of soil and water, also leading to resistance in the environment <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. Human health can be affected when these pesticides are similar to antibiotics used in human medicine <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. A paper titled “The source, fate and prospect of antibiotic resistance genes in soil: A review” highlights the impact of ARGs on public health in soil environments specifically. Soil is a reservoir and propagation hotspot for ARGs <xref ref-type="bibr" rid="scirp.146045-11">
      [11]
     </xref>. Factors like microbiome composition, soil physicochemical properties (pH and moisture), antibiotics, heavy metals, polycyclic aromatic hydrocarbons, and pesticides, were discussed in relation to their impact on ARGs. Among these factors, microbial community structure, mobile genetic elements, pH, and heavy metals were identified as having a significant influence on ARG profiles <xref ref-type="bibr" rid="scirp.146045-11">
      [11]
     </xref>.</p>
    <p>Aquaculture operations frequently use antibiotics, leading to contamination of water sources <xref ref-type="bibr" rid="scirp.146045-7">
      [7]
     </xref>. A study by Doğan and Önalan (2023) <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref> aimed to determine the variations of antimicrobial resistance genes (specifically tet and str genes that confer resistance to tetracycline and streptomycin respectively) in freshwater fish species. Antimicrobial resistance is a concerning issue in public health, and understanding the presence and diversity of resistance genes in different environments, such as freshwater ecosystems, can provide insights into potential sources and pathways of resistance transmission <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref>. By analyzing these genes in freshwater fish species, the researchers sought to contribute to our understanding of antimicrobial resistance dynamics in aquatic environments <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref>. The researchers sampled 70 fish belonging to seven different species. They were collected from two regions, one region with no fish farming activities and another region with fish farming activities. They found that two species, C. carpio and C. regium had higher tet and str gene expression compared to a control group which had no antibiotic use <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref>. In other species, a lower but significant expression level was seen <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref>. The researchers concluded that even in the absence of antibiotic use, the fish recirculating water system can cause the spread of antibiotic resistance genes <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref>. Other factors such as pH and heavy metals can also contribute <xref ref-type="bibr" rid="scirp.146045-12">
      [12]
     </xref>. Ultimately, the ecosystem serves as a connection between humans, animals, and the environment <xref ref-type="bibr" rid="scirp.146045-13">
      [13]
     </xref>. AMR transmission and the mixing of mobile genetic elements are thus able to spread to hosts <xref ref-type="bibr" rid="scirp.146045-13">
      [13]
     </xref>. A paper by Samreen et al. (2021) <xref ref-type="bibr" rid="scirp.146045-13">
      [13]
     </xref> describes how biocides and heavy metals contribute to the development and dissemination of AMR. These metals have resistance mechanisms similar to antibiotics such as reduced membrane permeability, metal alteration, efflux of metals, target site modification, and metal sequestration. Biocidal products exert microbiostatic or microbicidal effects against various microorganisms.</p>
   </sec>
   <sec id="s1_3">
    <title>
     <xref ref-type="bibr" rid="scirp.146045-"></xref>1.3. Antibiotic Resistance in Specific Bacterial Species</title>
    <p>Antibiotic resistance in bacterial species occurs through various mechanisms, including genetic mutations, horizontal gene transfer, and selective pressure from the overuse and misuse of antibiotics. When bacteria are exposed to antibiotics, those with mutations that confer resistance to the drug are more likely to survive and propagate, passing on these resistant traits to their progeny. Horizontal gene transfer allows bacteria to acquire resistance genes from other bacteria, further spreading resistance across species. The global issue of antibiotic resistance is exacerbated by the extensive and often inappropriate use of antibiotics in both human healthcare and agriculture, creating an environment in which resistance can thrive <xref ref-type="bibr" rid="scirp.146045-14">
      [14]
     </xref>. Additionally, the overprescription of antibiotics for viral infections, lack of proper diagnostics, and inadequate infection control measures contribute to the accelerating spread of resistance <xref ref-type="bibr" rid="scirp.146045-15">
      [15]
     </xref>. As bacteria evolve to resist multiple classes of antibiotics, previously treatable infections become increasingly difficult to manage, leading to higher mortality rates, prolonged hospital stays, and greater healthcare costs. The World Health Organization (WHO) has classified antibiotic resistance as one of the most urgent global health threats, as it undermines the effectiveness of life-saving antibiotics and limits treatment options for common infections, such as pneumonia, tuberculosis, and urinary tract infections <xref ref-type="bibr" rid="scirp.146045-16">
      [16]
     </xref>. The interconnected nature of global travel, trade, and food supply chains further facilitates the spread of resistant bacteria across borders, making this a problem that requires urgent global cooperation and action.</p>
   </sec>
   <sec id="s1_4">
    <title>1.4. WHO-Identified Priority Pathogens</title>
    <p>The World Health Organization (WHO) has highlighted several critical pathogens that pose an immediate threat due to their increasing resistance to available treatments. Among these, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa are notable examples. Recent studies have shown that E. coli is particularly concerning due to its growing resistance to fluoroquinolones and third-generation cephalosporins, often driven by the acquisition of extended-spectrum beta-lactamases (ESBLs) and carbapenemases <xref ref-type="bibr" rid="scirp.146045-17">
      [17]
     </xref>. Similarly, K. pneumoniae has seen an alarming rise in carbapenem resistance, linked to the spread of New Delhi metallo-beta-lactamase (NDM)-producing strains <xref ref-type="bibr" rid="scirp.146045-18">
      [18]
     </xref>. S. aureus, including methicillin-resistant strains (MRSA), remains a significant hospital-acquired pathogen, with a troubling trend toward multidrug resistance <xref ref-type="bibr" rid="scirp.146045-19">
      [19]
     </xref>. P. aeruginosa, notorious for its environmental resilience, has shown increasing resistance to beta-lactams, aminoglycosides, and fluoroquinolones, complicating treatment options <xref ref-type="bibr" rid="scirp.146045-20">
      [20]
     </xref>. These species, among others, exemplify the broader issue of ABR, which threatens to undermine the effectiveness of antibiotics, complicating the treatment of infections and increasing morbidity and mortality worldwide. Recent literature continues to underscore the urgency of global surveillance and the need for innovative solutions to combat this growing resistance crisis.</p>
   </sec>
   <sec id="s1_5">
    <title>1.5. Focus on Salmonella enterica</title>
    <p>This review will narrow its focus to a specific bacterial genus, Salmonella, which continues to be of concern in both environmental and clinical contexts. There are physiological, biochemical, environmental, and molecular factors that allow for its resistance <xref ref-type="bibr" rid="scirp.146045-21">
      [21]
     </xref>. S. enterica is a gram-negative bacterium that is passed through contaminated food and water between humans and animals <xref ref-type="bibr" rid="scirp.146045-22">
      [22]
     </xref>. Salmonellosis causes gastroenteritis, septicemia, and enteric fever. Enteric fevers are caused by S. enterica serovars Typhi and Paratyphi <xref ref-type="bibr" rid="scirp.146045-22">
      [22]
     </xref>, which are human-restricted. The epidemiology of typhoid and other enteric fevers involve person-to-person transmission because these organisms do not have a significant animal reservoir <xref ref-type="bibr" rid="scirp.146045-23">
      [23]
     </xref>. Unlike Typhi and Paratyphi, nontyphoidal Salmonellae (NTS) are not human-restricted <xref ref-type="bibr" rid="scirp.146045-22">
      [22]
     </xref>. The S. enterica serotypes Typhimurium and Enteritidis have reservoirs in farm animals, thus consumption of contaminated and raw meat is the main mode of NTS transmission <xref ref-type="bibr" rid="scirp.146045-23">
      [23]
     </xref>. Nontyphoidal salmonellosis is similar to gastroenteritis as symptoms may involve nausea and diarrhea <xref ref-type="bibr" rid="scirp.146045-22">
      [22]
     </xref>. Salmonella can also cause chronic conditions such as Reiter’s syndrome, a form of arthritis <xref ref-type="bibr" rid="scirp.146045-22">
      [22]
     </xref>. Salmonellae have a lipopolysaccharide coat and possess the ability to invade cells and replicate intracellularly <xref ref-type="bibr" rid="scirp.146045-23">
      [23]
     </xref>. These bacteria are found in the ileum and colon and they invade the intestinal epithelium by binding to receptors on the epithelial cell surface, leading to an acute inflammatory response <xref ref-type="bibr" rid="scirp.146045-23">
      [23]
     </xref>. In a recent study by Robertson et al. (2023) <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>, Illumina sequencing data was used to provide a current characterization of plasmids and their AMR associations within the Salmonella species. About 16% of Salmonella cases in the US exhibit resistance to at least one essential antibiotic <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>. Bacteria can acquire antibiotic resistance through mutations or mobile genetic elements (MGEs) that carry genes that confer this resistance <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>. Plasmids are an example of MGEs which allow for horizontal transfer of AMR genes <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>. Although mostly circular, linear plasmids are found in some gram negative bacteria like Salmonella <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>. Linear plasmids are found to confer advantages such as enhanced nuclear translocation <xref ref-type="bibr" rid="scirp.146045-25">
      [25]
     </xref>. The authors describe replicon and relaxase typing as efficient methods for plasmid classification which give us information on AMR and virulence <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>. The results of this study were that Salmonella virulence plasmids were largely inherited vertically and that plasmids identified in this bacterium have the ability to replicate in other pathogens and be transferred between commensal and pathogenic bacteria <xref ref-type="bibr" rid="scirp.146045-24">
      [24]
     </xref>. Vertical transfer is when the plasmid is transported from the mother to daughter cells during cell division, whereas horizontal transfer occurs through conjugation <xref ref-type="bibr" rid="scirp.146045-26">
      [26]
     </xref>. In vertical transfer, cells divide and produce copies of themselves, leading to more cells over time <xref ref-type="bibr" rid="scirp.146045-26">
      [26]
     </xref>. This mode of transfer also ensures that resistance traits are inherited by subsequent generations <xref ref-type="bibr" rid="scirp.146045-26">
      [26]
     </xref>.</p>
   </sec>
   <sec id="s1_6">
    <title>1.6. Environmental Presence of ESKAPE Pathogens</title>
    <p>Another group of pathogenic bacteria, the “ESKAPE” pathogens include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species). These pathogens can escape bactericidal activity of antibiotics, making them a great threat to human health <xref ref-type="bibr" rid="scirp.146045-27">
      [27]
     </xref>. <xref ref-type="fig" rid="fig1">
      Figure 1
     </xref> highlights their mechanisms of antibiotic resistance. In a review paper by Marutescu et al. (2023), it was found that WWTPs provided these bacteria with additional virulence determinants <xref ref-type="bibr" rid="scirp.146045-28">
      [28]
     </xref>. Of these pathogens, those that are mostly found in the environment are P. aeruginosa and enterococci.</p>
    <p>P. aeruginosa, an aerobic gram-negative bacterium is found in the environment and causes nosocomial infections <xref ref-type="bibr" rid="scirp.146045-27">
      [27]
     </xref>. It demonstrates both intrinsic and acquired mechanisms of resistance including efflux pumps, decreased outer membrane permeability, and lack of proteins that allow diffusion of antibiotics across the outer membrane <xref ref-type="bibr" rid="scirp.146045-27">
      [27]
     </xref>. Due to this bacterium being adapted to low osmolarity environments, it is often found in water sources. 95% of hospital wastewater samples were positive for multidrug-resistant P. aeruginosa in this study. In a paper by Gervasoni et al. (2023), this bacterium’s ability to form biofilms was discussed. Due to this, they are found in a variety of aquatic environments <xref ref-type="bibr" rid="scirp.146045-29">
      [29]
     </xref>.</p>
    <p>
     <xref ref-type="bibr" rid="scirp.146045-"></xref></p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146045-"></xref>Figure 1. Mechanisms of antibiotic resistance in ESKAPE pathogens. Adapted from: <xref ref-type="bibr" rid="scirp.146045-28">
        [28]
       </xref>.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2272186-rId17.jpeg?20250930041854" />
    </fig>
    <p>Enterococci are gram-positive cocci which can survive in hostile environments. E. faecalis and E. faecium cause most of the enterococcal infections <xref ref-type="bibr" rid="scirp.146045-27">
      [27]
     </xref>. This bacterial species is becoming increasingly resistant due to various reasons including the large use of broad-spectrum antibiotics in hospitals <xref ref-type="bibr" rid="scirp.146045-27">
      [27]
     </xref>. Broad spectrum antibiotics include penicillins and cephalosporins which increase normal gram-negative intestinal microbiota, thereby promoting intestinal colonization of E. faecium <xref ref-type="bibr" rid="scirp.146045-27">
      [27]
     </xref>. A genomic analysis by Shobo et al. (2023) provided information on the spread of E. faecalis in hospitals as well as its acquisition of resistant genes is such settings <xref ref-type="bibr" rid="scirp.146045-30">
      [30]
     </xref>. The researchers found that this specie was responsible for over 80% of hospital cases and can acquire additional resistance through the transfer of plasmids, prophages, insertion sequences, and other mobile genetic elements <xref ref-type="bibr" rid="scirp.146045-30">
      [30]
     </xref>. Another study by Paul B. Tchounwou (2015) isolated Enterococcus species in hospital wastewater and effluent of WWTPs instead of looking at the internal hospital environment <xref ref-type="bibr" rid="scirp.146045-31">
      [31]
     </xref>. He determined that 62 of the 66 isolates belonged to the Enterococcus genus, with majority being E. faecalis <xref ref-type="bibr" rid="scirp.146045-31">
      [31]
     </xref>. In these isolated species, he found a high number of genotypic virulence factors including Zn-metalloendopeptidase (gelE), collagen binding protein (ace) and endocarditic antigen (efaA) <xref ref-type="bibr" rid="scirp.146045-31">
      [31]
     </xref>.</p>
    <sec id="s1">
     <title>2. Antibiotic Leakage into the Environment</title>
    </sec>
    <sec id="s2_7">
     <title>
      <xref ref-type="bibr" rid="scirp.146045-"></xref>2.1. How and Where Does the Antibiotic Leakage Occur</title>
     <p>MDR species of Salmonella and other pathogens have been identified in environmental water sources. These waterways are a potential reservoir for MDR. There are several potential sources of these resistant bacteria including commercial agriculture practices, water waste treatment plants, medical center waste disposal, and intrinsic antibiotic resistance already present in bacterial populations. These environmental waterways not only offer a reservoir for MDR bacteria but may also potentially present opportunities for pathogenic bacteria to transfer their antibiotic resistance genes to nonpathogenic populations.</p>
     <p>Antibiotics enter the environment through feces, urine, manure, and waste or unused antibiotics from drug production, medical systems, and households <xref ref-type="bibr" rid="scirp.146045-32">
       [32]
      </xref>. These antibiotics can contaminate the soil, surface water, and groundwater through leaching or runoff <xref ref-type="bibr" rid="scirp.146045-32">
       [32]
      </xref>. Groundwater, which serves as our primary source of freshwater, has been found to contain pharmaceuticals and personal care products <xref ref-type="bibr" rid="scirp.146045-33">
       [33]
      </xref>. As a result, antibiotics accumulate in groundwater and pose ecological and human health risks. Continuous release of antibiotics into groundwater leads to selection of ARBs and ARGs <xref ref-type="bibr" rid="scirp.146045-33">
       [33]
      </xref>. A global review titled “Antibiotics and antibiotic resistant genes in groundwater” aims to understand the transport of antibiotics and ARGs, analyzes contamination profiles, and identifies key drivers of ARBs <xref ref-type="bibr" rid="scirp.146045-33">
       [33]
      </xref>.</p>
     <p>The decomposition of solid waste in landfills contributes to the evolution of the antibiotic resistome <xref ref-type="bibr" rid="scirp.146045-32">
       [32]
      </xref>. Consequently, antibiotics and antibiotic resistomes are discharged into the environment or wastewater treatment plants (WWTPs) for further treatment, making landfills and leachates important reservoirs of antibiotics <xref ref-type="bibr" rid="scirp.146045-32">
       [32]
      </xref>. Zhang et al. found that landfills are hotspots of AR transmission and the wide distribution of antibiotics, antibiotic resistant bacteria (ARBs), and ARGs in refuse and leachates furthers AR transmission risk <xref ref-type="bibr" rid="scirp.146045-32">
       [32]
      </xref>. Antibiotic residues, bacterial communities, MGEs, heavy metals, organic matter, and physicochemical properties all play a role in the spread of AR <xref ref-type="bibr" rid="scirp.146045-32">
       [32]
      </xref>. Wastewater treatment is the largest reservoir and hurdle to clear. The presence of carbon sources, electron acceptors, particles onto which bacteria can adsorb, as well as a stable pH and temperature allow for a diversity of microorganisms to live in wastewater <xref ref-type="bibr" rid="scirp.146045-34">
       [34]
      </xref>. ARGs from the environment, humans, and animals are brought together here <xref ref-type="bibr" rid="scirp.146045-34">
       [34]
      </xref>. WWTPs play a role in maintaining and spreading ARGs and ARBs <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Antibiotic residues in wastewater treatment plants can shape the microbial community and facilitate the horizontal transfer of ARGs <xref ref-type="bibr" rid="scirp.146045-36">
       [36]
      </xref>. The occurrence of ARGs and ARB in WWTPs has been widely reported, and some studies have detected ARGs conferring resistance to all categories of antibiotics <xref ref-type="bibr" rid="scirp.146045-36">
       [36]
      </xref>.</p>
    </sec>
    <sec id="s2_8">
     <title>
      <xref ref-type="bibr" rid="scirp.146045-"></xref>2.2. Water Sources as Reservoirs</title>
     <p>There are many potential sources of both antibiotic leakage and MDR bacteria that could be contributing to the maintenance of resistance bacterial populations in the environment. These include commercial agriculture practices, wastewater treatment plants, medical center waste disposal, and intrinsic antibiotic resistance <xref ref-type="bibr" rid="scirp.146045-37">
       [37]
      </xref>. Some examples of intrinsic antibiotic resistance include lack of a target site, efflux pumps, high neutralizing capacity, little drug concentration, and response to stress <xref ref-type="bibr" rid="scirp.146045-38">
       [38]
      </xref>. The greatest amounts of MDR bacteria, as well as the most diversity in AMR was found to be in waterways with runoff from wastewater treatment plants <xref ref-type="bibr" rid="scirp.146045-37">
       [37]
      </xref>. Urban wastewater treatment plants offer an environment that is rich in organic nutrients, large amounts of bacteria, and strong selective pressures from pharmaceutical residues and pesticides, contributing to MDR and AMR <xref ref-type="bibr" rid="scirp.146045-37">
       [37]
      </xref>.</p>
     <p>In a study by Berglund et al., it was found that wastewaters and environments impacted by wastewater were hotspots for initial mobilization of resistant genes. Various metagenomes were analyzed and it was found that amongst them all, wastewater had the highest abundance of origin species and mobilizing elements <xref ref-type="bibr" rid="scirp.146045-8">
       [8]
      </xref>. Another study by Karkman et al. also discussed wastewater and its treatment plants as hotspots for selection and transfer of AMR. These wastewater systems act as reservoirs and sources of antibiotic resistance, as well as potential sites for horizontal gene transfer between different bacterial species <xref ref-type="bibr" rid="scirp.146045-39">
       [39]
      </xref>.</p>
     <p>Another paper focused on recreational waters being recipients and natural reservoirs for AMR bacteria and ARGs <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Untreated wastewater, medical waste, treated wastewater, biosolids, agriculture, aquaculture, and birds were also explored as contributing factors <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Firstly, there is a high concentration of pathogenic and nonpathogenic microbes and antibiotics in untreated wastewater <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Overflows of sewers can lead to wastewater entering surface waters. In the US, there are 2300 - 7500 sewer overflows each year <xref ref-type="bibr" rid="scirp.146045-5">
       [5]
      </xref>. Also, the presence of antibiotics and their residues in municipal wastewater influent can be attributed to pharmaceutical disposal, excretion from patients undergoing pharmaceutical treatments, and the use of antimicrobials for cleaning surfaces, hands, or clothing <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Additionally, the blending of raw sewage with pre-treated and/or raw medical waste in hospitals can create a hotspot for the transfer of antibiotic resistance genes <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Treated wastewater can be discharged to surface waters and also serve as a point source for AMR <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. This paper cites multiple studies which discuss that wastewater treatment does not reduce the proportion of resistant bacteria. In the United States, municipal waste undergoes primary and secondary wastewater treatment processes, often followed by disinfection steps to eliminate pathogens before releasing the treated effluent into surface waters <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. The frequency of disinfection may vary depending on the intended use of the receiving water bodies, with some wastewater treatment plants implementing seasonal disinfection rather than year-round <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. These processes may only partially remove pharmaceuticals, including antibiotics <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Studies have detected various pharmaceutical compounds, including both human and veterinary antibiotics, in the effluent of treated wastewater, suggesting that antibiotic residues can persist even after treatment <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Biosolids refers to the sludge generated by sewage treatment which is used as soil amendment <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. This may be a source of AMR as well. Additionally, over 60% of livestock and poultry receive antibiotics, making animal feeding operations a large source of antibiotics <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. Lastly, fecal matter of wild birds, which is widespread in many regions, can be dispersed in the environment, potentially leading to direct contamination of surface waters or through surface runoff <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>. The potential contribution of wild birds and seagulls to the dissemination of ARBs and ARGs requires additional investigation, particularly considering their long-distance migration behavior <xref ref-type="bibr" rid="scirp.146045-9">
       [9]
      </xref>.</p>
     <p>To better illustrate the scale of antibiotic release and antimicrobial resistance across sectors, <xref ref-type="table" rid="table1">
       Table 1
      </xref> summarizes key quantitative data from studies included in this review, highlighting the burden of antibiotic release, ARG pervalence, and resistance rates across environmental and clinical contexts.</p>
     <table-wrap id="table1">
      <label>
       <xref ref-type="table" rid="table1">
        Table 1
       </xref></label>
      <caption>
       <title>
        <xref ref-type="bibr" rid="scirp.146045-"></xref>Table 1. Comparative quantitative data on antimicrobial resistance (AMR), antibiotic residues, and ARG prevalence across environmental and clinical sources.</title>
      </caption>
      <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
       <tr> 
        <td class="custom-bottom-td acenter" width="23.50%"><p style="text-align:center">Source/Environment</p></td> 
        <td class="custom-bottom-td acenter" width="14.35%"><p style="text-align:center">Region/Setting</p></td> 
        <td class="custom-bottom-td acenter" width="28.85%"><p style="text-align:center">Parameter</p></td> 
        <td class="custom-bottom-td acenter" width="16.48%"><p style="text-align:center">Reported Value</p></td> 
        <td class="custom-bottom-td acenter" width="16.82%"><p style="text-align:center">Reference</p></td> 
       </tr> 
       <tr> 
        <td class="custom-top-td acenter" width="23.50%"><p style="text-align:center">Food-animal production</p></td> 
        <td class="custom-top-td acenter" width="14.35%"><p style="text-align:center">U.S.</p></td> 
        <td class="custom-top-td acenter" width="28.85%"><p style="text-align:center">Antimicrobials used annually</p></td> 
        <td class="custom-top-td acenter" width="16.48%"><p style="text-align:center">&gt;25 million lb/yr</p></td> 
        <td class="custom-top-td acenter" width="16.82%"><p style="text-align:center">Williams et al. 2016 <xref ref-type="bibr" rid="scirp.146045-10">
           [10]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Animal fecal waste</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">U.S.</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">Antibiotics excreted</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">~13.5 million lb/yr</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Williams et al. 2016 <xref ref-type="bibr" rid="scirp.146045-10">
           [10]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Sewer overflows</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">U.S.</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">Untreated wastewater overflows per year</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">2300 - 7500 events/yr</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Nappier et al. 2020 <xref ref-type="bibr" rid="scirp.146045-9">
           [9]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Hospital wastewater (P. aeruginosa)</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">–</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">MDR P. aeruginosa prevalence in samples</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">95% positive</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Gervasoni et al. 2023 <xref ref-type="bibr" rid="scirp.146045-29">
           [29]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Wastewater effluent (Enterococcus)</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">South Africa</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">Enterococcus isolates from effluent</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">62 of 66 isolates (≈94%)</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Iweriebor et al. 2015 <xref ref-type="bibr" rid="scirp.146045-31">
           [31]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Hospital infections (E. faecalis)</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">South Africa</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">Share of hospital enterococcal infections</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">&gt;80%</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Shobo et al. 2023 <xref ref-type="bibr" rid="scirp.146045-30">
           [30]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Clinical burden—Salmonella</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">U.S.</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">Resistant to ≥1 essential antibiotic</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">~16% of cases</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Robertson et al. 2023 <xref ref-type="bibr" rid="scirp.146045-24">
           [24]
          </xref></p></td> 
       </tr> 
       <tr> 
        <td class="acenter" width="23.50%"><p style="text-align:center">Efflux-pump inhibitor (MDR Salmonella)</p></td> 
        <td class="acenter" width="14.35%"><p style="text-align:center">Laboratory isolates</p></td> 
        <td class="acenter" width="28.85%"><p style="text-align:center">Reduction in tetracycline MIC with EPIs</p></td> 
        <td class="acenter" width="16.48%"><p style="text-align:center">16 - 32 × decrease</p></td> 
        <td class="acenter" width="16.82%"><p style="text-align:center">Le et al. 2018 <xref ref-type="bibr" rid="scirp.146045-60">
           [60]
          </xref></p></td> 
       </tr> 
      </table>
     </table-wrap>
    </sec>
    <sec id="s2_9">
     <title>
      <xref ref-type="bibr" rid="scirp.146045-"></xref>2.3. Agriculture and Commercial Food Farms</title>
     <p>
      <xref ref-type="bibr" rid="scirp.146045-"></xref>Use of antibiotics in agricultural practices is another concern. A paper by Jochum et al. (2021) <xref ref-type="bibr" rid="scirp.146045-40">
       [40]
      </xref> discussed commercial chicken farms housing bacteria that are broadly resistant to last resort antibiotics. Their study aimed to detect bacteria in poultry farms which was resistant to colistin, carbapenems, and beta lactams, potentiate virulence risk in E. coli isolates, and assess AMR transfer via conjugates <xref ref-type="bibr" rid="scirp.146045-40">
       [40]
      </xref>. The researchers collected cecal contents from laying hens raised in both conventional cage (CC) and cage-free (CF) farms at three different maturity stages <xref ref-type="bibr" rid="scirp.146045-40">
       [40]
      </xref>. These samples were then randomly tested for the presence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter (CRA), and colistin-resistant Escherichia coli (CRE) using selective CHROMagar™ media <xref ref-type="bibr" rid="scirp.146045-40">
       [40]
      </xref>. They found that AmpC beta-lactamase was transferable through a large plasmid in ESBL-producing E. coli from CC <xref ref-type="bibr" rid="scirp.146045-40">
       [40]
      </xref>. The plasmid was transferable to different hosts, demonstrating its ability to transfer between both virulent and non-virulent bacteria <xref ref-type="bibr" rid="scirp.146045-40">
       [40]
      </xref>.</p>
     <p>Microplastics (MPs) play a role in the spread of ARGs in the environment. Due to the vast use of plastics and their release into the environment due to industrial activities, bodies of water are prone to microplastic contamination <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. MPs allow for microbial colonization and formation of biofilm, where horizontal gene transfer can occur <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. Also, widespread use of antibiotics leads to their release into the environment, mainly through wastewater <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. Therefore, wastewater treatment plants, especially in hospital plants, serve as hotspots for the selection of ARGs and their diffusion in the environment <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. Consequently, the presence of drug-resistant bacteria and antimicrobial resistance genes on MPs makes them capable of transporting and spreading these genes and harmful microorganisms <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. This emerging issue of microplastic-associated antimicrobial resistance poses a threat to the environment and, subsequently, to human health <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. MPs have been found in various sources, including water supplies and even food and drinking water, highlighting the extent of the problem <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. One of the concerning aspects of MPs is their ability to act as carriers, adsorbing chemicals and microorganisms from their surroundings, facilitated by the formation of biofilms <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. Additionally, MPs have been identified as potential vectors for the long-distance dissemination of antibiotic resistance <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. This is particularly concerning in hospital wastewater, where higher concentrations of antibiotic resistance genes (ARGs) and antibiotics are often found compared to urban wastewater <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. The presence of ARGs on MPs in this environment can contribute to the selection and horizontal transfer of resistance genes, further amplifying the spread of antibiotic resistance <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>. Addressing the presence of ARGs on MPs is a critical issue that requires effective management of plastic waste disposal and the implementation of appropriate wastewater treatment strategies. Particularly in hospital settings, where the risk of antibiotic resistance is higher, it is crucial to ensure proper management practices to mitigate the diffusion of antibiotic resistance and safeguard human health <xref ref-type="bibr" rid="scirp.146045-41">
       [41]
      </xref>.</p>
    </sec>
   </sec>
   <sec id="s3">
    <title>
     <xref ref-type="bibr" rid="scirp.146045-"></xref>3. Spread of Resistance from Pathogenic to Non-Pathogenic Bacteria</title>
    <p>Pathogenic bacteria cause disease and invade host cells whereas non-pathogenic bacteria do not. Non-pathogenic bacteria may however carry genes which increase a pathogen’s ability to amplify and spread <xref ref-type="bibr" rid="scirp.146045-42">
      [42]
     </xref>. A paper by Dionisio et al. (2023) <xref ref-type="bibr" rid="scirp.146045-42">
      [42]
     </xref> discusses non-pathogenic bacteria and their involvement in the dissemination of virulence and resistance genes. The authors discuss their ability to possess virulent genes, drug resistance genes, as well as non-housekeeping genes that can enhance the success of pathogens during infection <xref ref-type="bibr" rid="scirp.146045-42">
      [42]
     </xref>. Non-pathogenic cells that lack these genes can aid in the transfer of such genes to pathogenic cells by amplifying their presence within microbiomes <xref ref-type="bibr" rid="scirp.146045-42">
      [42]
     </xref>. Additionally, physical contact networks involving humans contribute to the transmission of pathogens within our population <xref ref-type="bibr" rid="scirp.146045-42">
      [42]
     </xref>. These networks refer to physical contact between families, friends, and sexual relationships.</p>
    <p>A paper by José L. Martínez (2012) <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref> discusses bottlenecks modulating the transfer, spread, and stability of antibiotic resistance genes. Since human pathogens acquire resistance genes via horizontal gene transfer originating in non-pathogenic bacteria, it is important to consider how natural, non-clinical ecosystems contribute to the evolution of resistance <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. The author analyzed factors such as founder effects, ecological connectivity, fitness costs, and second-order selection <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. The founder effect refers to a situation where the first transferred gene becomes dominant <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. When multiple resistance genes with similar profiles are present, one gene typically prevails in human bacterial pathogens <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. This outcome can be influenced by fitness costs and chance. For example, the TEM-1 beta-lactamase became predominant among Enterobacteriaceae family members after its acquisition and rapid spread <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Although many beta-lactamases exist, TEM-1 prevailed due to strong selective pressure from antibiotics <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. However, the introduction of new antibiotics or inhibitors can lead to the evolution of different beta-lactamases <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Ecological connectivity is related to both the spatial arrangement of microorganisms and their ability to transfer genetic material <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. In natural environments, there is a low concentration of antibiotics unlike human-related environments like WWTPs <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. In environments like WWTPs, human pathogens and non-pathogenic bacteria coexist, so there is a higher chance for the transfer of resistance genes to bacterial pathogens <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Also, some microorganisms form genetic exchange communities which share features like plasmids or transposons <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Therefore, if a mobile genetic element carrying a resistance gene enters a genetic exchange community, it can cause the gene to become fixed in bacterial pathogen populations <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. The spread in certain bacteria is however limited by fitness costs because some resistant bacteria are outcompeted by susceptible ones <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Fitness costs may be compensated by mutations that allow resistance to persist <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Lastly, resistance genes can be maintained in habitats without strong antibiotic pressure through second-order selection <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. This refers to when selection for one antibiotic can select for the entire array of resistance genes on a specific genetic element <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Cross-selection is another process where selection for one compound results in resistance to another, such as multidrug efflux pumps conferring resistance to antibiotics, biocides, and heavy metals <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>. Plasmids may also encode stability systems that increase the chances of resistance gene maintenance <xref ref-type="bibr" rid="scirp.146045-43">
      [43]
     </xref>.</p>
    <p>Plasmids allow for the possibility of rapid horizontal transfer of resistance among bacterial populations <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>. This is highlighted in a paper titled “Dissemination of plasmid-encoded AmpC β-lactamases in antimicrobial resistant Salmonella serotypes originating from humans, pigs and the swine environment”. MDR Salmonella carries resistance genes on either their chromosome or mobile genetic elements <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>. Commercial agriculture offers a reservoir for MDR genes that could potentially be exchanged through horizontal transfer <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>. In this study Salmonella strains were selected from humans, pigs and the farm environment to determine if the exchange of material is possible <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>. MDR plasmids were found in all isolates. Those taken from pigs and their environment had the highest frequency of MDR <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>. All three sites contained similar resistance profiles. Class I and II integrons were also found and could be important to the transfer of MDR genes <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>. Similar plasmid profiles were also associated with serotypes that contained the same MDR pattern on all samples from different sites <xref ref-type="bibr" rid="scirp.146045-44">
      [44]
     </xref>.</p>
    <p>Multiple drug resistance (MDR) in Enterobacteriaceae, particularly Salmonella and Escherichia coli, is a major public health concern due to plasmid-mediated gene transfer. We analyzed Salmonella enterica clinical isolates for plasmid-borne MDR transfer to E. coli and assessed the fitness impact of carrying an Inc A/C plasmid. Our findings show that Inc A/C plasmids provide a fitness advantage in macrophages without imposing significant costs under stress conditions. These results highlight the role of plasmids in enhancing pathogenicity and underscore the need to better understand MDR dissemination mechanisms <xref ref-type="bibr" rid="scirp.146045-45">
      [45]
     </xref>.</p>
    <p>In another review paper titled “Plasmids, a Molecular Cornerstone of Antimicrobial Resistance in the One Health Era”, plasmid-mediated AMR and its mechanisms is discussed in detail. Plasmids not only spread ARGs between bacteria within the same microbiome, but also between microbiomes, and habitats, as well as between animals, humans, and the environment as shown in <xref ref-type="fig" rid="fig2">
      Figure 2
     </xref> <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>.</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146045-"></xref>Figure 2. Role of the environment in the emergence and mobilization of resistance genes to pathogens through horizontal gene transfer. Adapted from: <xref ref-type="bibr" rid="scirp.146045-47">
        [47]
       </xref>.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2272186-rId18.jpeg?20250930041856" />
    </fig>
    <p>ARGs are spread among bacteria by conjugation between bacteria which is the transfer of DNA and is facilitated by plasmids or by integrative conjugative elements (ICEs) <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. Some conjugative plasmids can even mobilize genes from plasmid recipients back to plasmid donors, a process called retromobilization, expanding their ecological role <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. Plasmids vary in size, and are categorized as conjugative, mobilizable, or non-mobilizable based on their ability to encode or use conjugative machinery <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. They contain genes essential for conjugation, alongside other genes responsible for stable maintenance, regulatory control, and replication of the plasmid <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. Additionally, plasmids often possess “accessory” regions, housing genes that promote their own or their host’s survival, such as toxin-antitoxin genes, metal and antibiotic resistance genes, virulence genes, as well as metabolic and catabolic functions <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. These accessory regions can vary between plasmids due to recombination events, resulting in mosaic plasmids. Mosaic plasmids contain genetic elements from different sources and are more prevalent among clinically relevant genera like Escherichia, Klebsiella, or Salmonella <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. They also carry a higher proportion of transposase and antibiotic resistance genes <xref ref-type="bibr" rid="scirp.146045-46">
      [46]
     </xref>. In another paper by Li and Zhang (2023) <xref ref-type="bibr" rid="scirp.146045-47">
      [47]
     </xref>, stressors that influence the transfer of plasmid mediated ARGs in the environment are discussed. These include environmental pollutants, including metals, pharmaceuticals, disinfectants, and microplastics <xref ref-type="bibr" rid="scirp.146045-47">
      [47]
     </xref>.</p>
    <sec id="s3_1">
     <title>3.1. Limitations and Knowledge Gaps</title>
     <p>Despite the growing body of literature linking AMR to environmental sources, substantial limitations persist across studies. Many investigations vary in sampling methods, microbial targets, and analytical techniques, making it difficult to compare findings or generalize trends across regions <xref ref-type="bibr" rid="scirp.146045-48">
       [48]
      </xref>. This heterogeneity limits our ability to quantify the relative importance of each exposure route. Moreover, uncertainties remain around how frequently environmental ARGs are transferred to clinically relevant pathogens, particularly under real-world conditions. Without consistent risk characterization, it is also challenging to assess the true human health burden posed by these environmental reservoirs. A clearer understanding of exposure dynamics, coupled with standardized monitoring frameworks, is needed to inform effective mitigation strategies and guide policy efforts.</p>
    </sec>
    <sec id="s3_2">
     <title>3.2. Consequences of Environmental Spread and State Regulation</title>
     <p>A review paper by Kraemer et al. (2019) <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref> discussed international policies aimed at mitigating antibiotic and AMR spread in the environment and gaps in existing policies. Each country is taking measures to address the issue of antibiotic pollution and antimicrobial resistance (AMR) in different ways and could serve as strategies to consider. Canada has implemented a domestic plan called “ Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action”. which focuses on surveillance, stewardship, and innovation <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. It addresses the misuse of antibiotics in the health and agriculture sectors and aims to develop policies and regulations to combat AMR <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Additionally, inappropriate and widespread use of antibiotics is a major contributor to AMR in India <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. The country has started monitoring and developing policies to address antibiotic pollution and AMR. India’s medical societies adopted national recommendations to promote antibiotic stewardship, which were later incorporated into the 2017 National Action Plan on Antimicrobial Resistance. This plan is based on the WHO Global Plan and aims to tackle AMR through various strategies <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Europe has been at the forefront of tackling the antibiotic pollution and AMR crisis <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. The European Union (EU) implemented the “EU One Health Action Plan against AMR” in 2017 <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. The plan focuses on making the EU a best practice region, boosting research and innovation, and shaping the global agenda <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Europe has banned the use of antibiotics as growth promoters in livestock and food animals since 2006 <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>, a policy that reportedly led to limited economic impact in high-income countries such as slight livestock productivity losses of 1 - 3% or modest short-term cost increases, closely offset by market price adjustments and also coincided with declines in AMR in livestock populations <xref ref-type="bibr" rid="scirp.146045-49">
       [49]
      </xref>. Policies and regulations have been implemented to address AMR in various sectors such as agriculture, aquaculture, human medicine, wastewater treatment, and the pharmaceutical industry <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. The U.S. Food and Drug Administration (FDA) wants to improve the judicious use of antibiotics in humans and animals by having medically important antibiotics (MIAs)—as in those that are used in human medicine —to fall under the oversight of veterinarians <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Additionally, penicillins, tetracycline, and sulfas would now need to be prescribed instead of being readily available over the counter <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. In addition to the FDA’s initiatives, the Centers for Disease Control and Prevention (CDC) has implemented the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), which outlines coordinated strategies to detect, respond to, and prevent AMR threats. This includes investments in public health infrastructure, expanding laboratory capacity, and enhancing data collection to monitor resistance trends across the country. The CDC also supports state and local health departments through programs like the Antibiotic Resistance (AR) Solutions Initiative, which funds regional efforts to contain and prevent outbreaks of resistant organisms <xref ref-type="bibr" rid="scirp.146045-50">
       [50]
      </xref>. These surveillance and stewardship programs have helped reduce deaths from antimicrobial resistane by approximately 18% overall and nearly 30% in hospitals during 2013-2019, though sustaining these gains requires ongoing investment in infrastructure and workforce <xref ref-type="bibr" rid="scirp.146045-51">
       [51]
      </xref>. At a broader level, the U.S. Department of Health and Human Services (HHS) is engaged in international collaborations to address AMR as a global health security threat. Through its Global Health Security Agenda (GHSA) and partnerships with the World Health Organization (WHO), the HHS Office of Global Affairs works to strengthen surveillance, research, and stewardship practices worldwide <xref ref-type="bibr" rid="scirp.146045-52">
       [52]
      </xref>.</p>
     <p>Although efforts are being made to strengthen surveillance systems, promote appropriate antibiotic use, and increase awareness about AMR, there are still gaps in existing policies, especially in regulating the release of antibiotics into the environment during pharmaceutical production <xref ref-type="bibr" rid="scirp.146045-39">
       [39]
      </xref>. Many action plans and policies lack specific measures to address antibiotic and antibiotic resistance gene pollution in natural environments <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. This omission is concerning as localized antibiotic pollution from these facilities can contribute to the evolution of resistance, potentially leading to the global spread of antibiotic-resistant bacteria and genes <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Additionally, there are currently no policies in place in the studied regions that specifically target the pollution of wastewater treatment plants (WWTPs) by antibiotics and antibiotic resistance genes <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. As existing WWTP designs do not effectively remove these substances, it is necessary to develop policies and technologies to regulate and reduce the presence of antibiotic resistance genes in WWTP effluents and biosolids <xref ref-type="bibr" rid="scirp.146045-35">
       [35]
      </xref>. Large-scale antibiotic pollution and resistance are significant public health challenges. While research on environmental dimensions of antibiotic resistance has increased, there are still many unknowns that require further investigation. Current studies focus on identifying resistance genes in the environment, but the associated risks of transmission and their impact on human health are not well understood. Antibiotic pollution can disrupt aquatic ecosystems and potentially affect human health. Effective policies should go beyond surveillance and consider the complex interconnections between human, animal, and environmental health. International cooperation and consistent policies are crucial to addressing this global problem.</p>
     <p>In addition to federal and international efforts, tackling environmental antimicrobial resistance requires action at the state level. States have jurisdiction over hospital systems, agricultural practices, and waste management. These areas are directly tied to how antibiotics are used and released into the environment. Due to this, state-level policies and action are essential for addressing environmental AMR and filling in the gaps that federal strategies may not fully cover.</p>
     <p>
      <xref ref-type="bibr" rid="scirp.146045-"></xref>In the state of Indiana currently, there are steps being taken to combat environmental AMR. The Indiana Department of Health aims to educate and provide recommendations to healthcare facilities, providers, and patients in the state <xref ref-type="bibr" rid="scirp.146045-53">
       [53]
      </xref>. Also, there are Antimicrobial Stewardship programs which are used to ensure appropriate antimicrobial use <xref ref-type="bibr" rid="scirp.146045-54">
       [54]
      </xref>. The Indiana Department of health provides online resources geared for providers tackling outpatient care regarding antimicrobial stewardship guidance.</p>
     <p>While these efforts are a step in the right direction, Indiana’s current approach to environmental AMR still has major limitations. According to the Indiana Department of Health, most of the state’s initiatives focus on increasing awareness and providing educational resources for healthcare providers and the public <xref ref-type="bibr" rid="scirp.146045-55">
       [55]
      </xref>. While awareness is important, there is a lack of concrete policies or regulations that directly target the environmental release of antibiotics or resistance genes. Stronger enforcement strategies which address antibiotic use in agriculture, pharmaceutical waste, and wastewater treatment are largely missing.</p>
    </sec>
    <sec id="s3_3">
     <title>3.3. Emerging Policy Approaches in Low- and Middle-Income Countries (LMICs)</title>
     <p>While most regulatory responses to AMR in the environment have emerged from high-income countries, initiatives in low- and middle-income nations are also growing. For example, India released a National Action Plan on Antimicrobial Resistance in 2017 that included a “One Health” framework explicitly targeting environmental contamination from pharmaceutical manufacturing and agricultural runoff. The state of Telangana, a major hub for antibiotic production, implemented effluent treatment plant requirements for pharmaceutical industries, aiming to reduce environmental discharges of active pharmaceutical ingredients <xref ref-type="bibr" rid="scirp.146045-56">
       [56]
      </xref> <xref ref-type="bibr" rid="scirp.146045-57">
       [57]
      </xref>. Although enforcement remains a challenge, such policies demonstrate that LMICs can adopt targeted interventions with global implications for AMR mitigation. Future efforts should focus on enhancing monitoring capacity, transparency, and international support to scale similar initiatives across resource-limited settings.</p>
    </sec>
   </sec>
   <sec id="s4">
    <title>4. Stopping Pathogenic Bacteria from Passing Mdr Genes to Non-Pathogenic Bacteria</title>
    <p>There are several recent studies which highlight treatments and processes to combat AMR.</p>
    <p>A paper by Azuma et al. (2022) <xref ref-type="bibr" rid="scirp.146045-58">
      [58]
     </xref>, discusses the inactivation of antibiotic-resistant bacteria in wastewater by ozone-based advanced water treatment processes <xref ref-type="bibr" rid="scirp.146045-58">
      [58]
     </xref>. Many recent studies examined methods such as Fenton treatment, ultrasonication, electrolysis, TiO<sub>2</sub> photocatalysis, persulfate oxidation, graphitic carbon nitride (g-C<sub>3</sub>N<sub>4</sub>) treatment, UV/chlorine treatment, and ozone (O<sub>3</sub>) treatment for water disinfection <xref ref-type="bibr" rid="scirp.146045-58">
      [58]
     </xref>. However, among these techniques, ozone (O<sub>3</sub>) is notable for its strong oxidation capability and effectiveness in decolorization, deodorization, and sterilization <xref ref-type="bibr" rid="scirp.146045-58">
      [58]
     </xref>. Ozone treatment has demonstrated efficacy not only in inactivating pathogenic microorganisms but also in removing micropollutants such as pharmaceutical residues and endocrine disruptors from wastewater <xref ref-type="bibr" rid="scirp.146045-58">
      [58]
     </xref>. This study’s results were that this treatment inactivates antimicrobial resistant and sensitive bacteria after ten minutes of treatment <xref ref-type="bibr" rid="scirp.146045-58">
      [58]
     </xref>.</p>
    <p>Another paper explored the potential of bacteriophages as a strategy for controlling antibiotic-resistant pathogens and understanding microbial interactions in wastewater treatment systems. Bacteriophages are viruses that infect and kill bacteria and are a potential alternative to antibiotics <xref ref-type="bibr" rid="scirp.146045-59">
      [59]
     </xref>. This paper cites their advantages which include their ability to target specific bacteria, their low toxicity, their effectiveness against ARBs and biofilms, and their ability to reproduce in response to pathogen density <xref ref-type="bibr" rid="scirp.146045-59">
      [59]
     </xref>. They also discuss various studies in which bacteriophages were able to successfully treat antibiotic-resistant bacteria in wastewater. For example, they have been effective against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, reducing bacterial populations and antibiotic resistance <xref ref-type="bibr" rid="scirp.146045-59">
      [59]
     </xref>. Another application of bacteriophages that is discussed in this paper is against membrane fouling, or formation of biofilms on membrane bioreactor systems which are used in the treatment of wastewater <xref ref-type="bibr" rid="scirp.146045-59">
      [59]
     </xref>. Several studies discussed in this paper demonstrate the ability of bacteriophages to target bacteria in biofouling. The authors of this paper concluded that lytic phages are preferred to avoid horizontal gene transfer <xref ref-type="bibr" rid="scirp.146045-59">
      [59]
     </xref>.</p>
    <p>Additionally, a study by Iakovides et al. (2019) <xref ref-type="bibr" rid="scirp.146045-60">
      [60]
     </xref> discussed continuous ozonation of wastewater as a promising treatment for the elimination of the selected antibiotics, ARBs, and ARGs <xref ref-type="bibr" rid="scirp.146045-60">
      [60]
     </xref>. The schematic of this treatment process is seen in <xref ref-type="fig" rid="fig3">
      Figure 3
     </xref>.</p>
    <fig id="fig3" position="float">
     <label>Figure 3</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146045-"></xref>Figure 3. Schematic of an ozonation reactor used for continuous treatment of wastewater to eliminate antibiotics, antibiotic-resistant bacteria (ARBs), and antibiotic resistance genes (ARGs). Adapted from: <xref ref-type="bibr" rid="scirp.146045-60">
        [60]
       </xref>.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2272186-rId19.jpeg?20250930041857" />
    </fig>
    <p>A paper by Le et al. (2018) <xref ref-type="bibr" rid="scirp.146045-61">
      [61]
     </xref>, discusses the removal of antibiotic residues, ARBs, and ARGs by membrane bioreactor systems. This research paper presents extensive data on the presence of 19 antibiotics, 10 types of antibiotic-resistant bacteria, and 15 antibiotic resistance genes (ARGs) in the untreated wastewater influent as well as during various treatment stages of conventional activated sludge (CAS) and membrane bioreactor (MBR) systems. The findings indicate that MBR systems demonstrated superior performance compared to CAS systems in terms of removing antibiotic-resistant bacteria, antibiotic resistance genes, and the majority of the target antibiotics <xref ref-type="bibr" rid="scirp.146045-61">
      [61]
     </xref>.</p>
    <p>Also, the paper titled “Increasing antimicrobial susceptibility of MDR Salmonella with the efflux pump inhibitor 1-(1-Naphthylmethyl)-piperazine” discusses the importance of developing effective measures against Salmonella due to its multidrug resistance. Bacterial antibiotic resistance is frequently mediated by efflux pumps <xref ref-type="bibr" rid="scirp.146045-62">
      [62]
     </xref>. In this research, the efficacy of two compounds, 1-(1-Naphthylmethyl)-Piperazine (NMP) and Phenylalanine-arginine β-naphthylamide (PaβN), in inhibiting efflux pump activity was investigated <xref ref-type="bibr" rid="scirp.146045-62">
      [62]
     </xref>. Specifically, their potential to synergistically enhance the effectiveness of the antibiotic tetracycline against tetracycline-resistant Salmonella was examined <xref ref-type="bibr" rid="scirp.146045-62">
      [62]
     </xref>. The findings revealed that these Efflux Pump Inhibitors (EPIs) were able to significantly reduce Salmonella’s resistance to tetracycline, with a 16 to 32-fold decrease observed in multiple tetracycline-resistant isolates <xref ref-type="bibr" rid="scirp.146045-62">
      [62]
     </xref>.</p>
    <p>Lastly, a review by Alaa Qumsani (2023) examines the potential of nanoparticles (NPs) as a highly efficient method to combat bacteria. NPs act both as carriers for natural antibiotics and antimicrobials as well as active agents against bacteria <xref ref-type="bibr" rid="scirp.146045-38">
      [38]
     </xref>. Moreover, the surface engineering of nanocarriers allows for targeted delivery and modification of various resistance mechanisms <xref ref-type="bibr" rid="scirp.146045-38">
      [38]
     </xref>. However, a limitation of this drug-delivery method is clearance through the reticuloendothelial system <xref ref-type="bibr" rid="scirp.146045-38">
      [38]
     </xref>. Overall, however, the use of NPs is a promising technique for overcoming bacterial resistance.</p>
   </sec>
   <sec id="s5">
    <title>5. Conclusions</title>
    <p>While antimicrobial resistance (AMR) is monitored in clinical settings, there is a lack thereof in environmental settings and AMR in environmental settings poses a significant threat to public health. Understanding the environmental aspect of AMR is crucial to understanding the routes of dissemination, selection of resistant microorganism, and risks posed to human health <xref ref-type="bibr" rid="scirp.146045-63">
      [63]
     </xref>.</p>
    <p>This review highlights the issue of antimicrobial resistance in the environment, with an emphasis on water sources. A significant area of concern is wastewater treatment plants, especially in hospital plants, which serve as hotspots for the selection of ARGs and their diffusion in the environment <xref ref-type="bibr" rid="scirp.146045-41">
      [41]
     </xref>. Of particular concern is the role of horizontal gene transfer in facilitating resistance gene dissemination among pathogenic and non-pathogenic bacteria. This literature review also discussed multidrug resistant Salmonella strains. NTS is spread through many ways including the fecal-oral route, contaminated food, animal contact, and rarely person-to-person <xref ref-type="bibr" rid="scirp.146045-64">
      [64]
     </xref>. Future steps involve reviewing recent studies which highlight treatments and processes to combat AMR. Ideas discussed in this literature review are ozone-based advanced water treatment processes, bacteriophages, ozonation, membrane bioreactor systems, and efflux pump inhibitors. These strategies show promise in combating AMR, however, improvement in local government policies in regulating antibiotic pollution and enhancements to wastewater treatment capabilities, are necessary in solidifying the battle against AMR.</p>
    <p>Publishing this review is essential to raise awareness of the increasing difficulty in treating antibiotic-resistant infections. Without intervention, the continued spread of AMR could render current treatments ineffective, leading to severe public health consequences.</p>
   </sec>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.146045-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     World Health Organization (2021) Antimicrobial Resistance. World Health Organization. &gt;https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Agyeman, W.Y., Bisht, A., Gopinath, A., Cheema, A.H., Chaludiya, K., Khalid, M., et al. (2022) A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections. Cureus, 14, e29956. &gt;https://doi.org/10.7759/cureus.29956
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Aljeldah, M.M. (2022) Antimicrobial Resistance and Its Spread Is a Global Threat. Antibiotics, 11, Article 1082. &gt;https://doi.org/10.3390/antibiotics11081082
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ventola, C.L. (2015) The Antibiotic Resistance Crisis. P&amp;T, 40, 277-283.
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zaman, S.B., Hussain, M.A., Nye, R., Mehta, V., Mamun, K.T. and Hossain, N. (2017) A Review on Antibiotic Resistance: Alarm Bells Are Ringing. Cureus, 9, e1403. &gt;https://doi.org/10.7759/cureus.1403
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nikaido, H. (1998) Antibiotic Resistance Caused by Gram-Negative Multidrug Efflux Pumps. Clinical Infectious Diseases, 27, S32-S41. &gt;https://doi.org/10.1086/514920
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Centers for Disease Control and Prevention (2024) Antimicrobial Resistance in the Environment and the Food Supply: Causes and How It Spreads. &gt;https://www.cdc.gov/antimicrobial-resistance/causes/environmental-food.html?CDC_AAref_Val=&gt;https://www.cdc.gov/drugresistance/environment.html 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Berglund, F., Ebmeyer, S., Kristiansson, E. and Larsson, D.G.J. (2023) Evidence for Wastewaters as Environments Where Mobile Antibiotic Resistance Genes Emerge. Communications Biology, 6, Article No. 321. &gt;https://doi.org/10.1038/s42003-023-04676-7
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nappier, S.P., Liguori, K., Ichida, A.M., Stewart, J.R. and Jones, K.R. (2020) Antibiotic Resistance in Recreational Waters: State of the Science. International Journal of Environmental Research and Public Health, 17, Article 8034. &gt;https://doi.org/10.3390/ijerph17218034
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Williams, M.R., Stedtfeld, R.D., Guo, X. and Hashsham, S.A. (2016) Antimicrobial Resistance in the Environment. Water Environment Research, 88, 1951-1967. &gt;https://doi.org/10.2175/106143016x14696400495974
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Han, B., Ma, L., Yu, Q., et al. (2022) The Source, Fate and Prospect of Antibiotic Resistance Genes in Soil: A Review. Frontiers in Microbiology, 13, Article 976657. &gt;https://doi.org/10.3389/fmicb.2022.976657 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Doğan, S. and Önalan, Ş. (2023) Determination of Antimicrobial Resistance Gene Variations Using Tet and Str Genes in Freshwater Fish Species. Cellular and Molecular Biology, 69, 150-155. &gt;https://doi.org/10.14715/cmb/2022.69.1.26
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Samreen, Ahmad, I., Malak, H.A. and Abulreesh, H.H. (2021) Environmental Antimicrobial Resistance and Its Drivers: A Potential Threat to Public Health. Journal of Global Antimicrobial Resistance, 27, 101-111. &gt;https://doi.org/10.1016/j.jgar.2021.08.001
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Smith, R.D. and Coast, J. (2022) The Economic Impact of Antibiotic Resistance: Why It Is a Global Issue. The Lancet Infectious Diseases, 7, 286-292.
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Murray, C.J.L., Ikuta, K.S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., et al. (2022) Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. The Lancet, 399, 629-655. &gt;https://doi.org/10.1016/s0140-6736(21)02724-0
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     World Health Organization (2021) Antimicrobial Resistance: Global Report on Surveillance. &gt;https://www.who.int/publications/i/item/9789241564748 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Johnson, L., Sabel, A., Burman, W.J., Everhart, R.M., Rome, M., MacKenzie, T.D., et al. (2008) Emergence of Fluoroquinolone Resistance in Outpatient Urinary Escherichia Coli Isolates. The American Journal of Medicine, 121, 876-884. &gt;https://doi.org/10.1016/j.amjmed.2008.04.039
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kumarasamy, K.K., Toleman, M.A., Walsh, T.R., et al. (2010) Emergence of a New Antibiotic Resistance Mechanism in India, Pakistan, and the UK: A Molecular, Biological, and Epidemiological Study. The Lancet Infectious Diseases, 10, 597-602.
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Abdelbary, M.M.H., Basset, P., Blanc, D.S. and Feil, E.J. (2017) The Evolution and Dynamics of Methicillin-Resistant Staphylococcus Aureus. In: Genetics and Evolution of Infectious Diseases, Elsevier, 553-572. &gt;https://doi.org/10.1016/b978-0-12-799942-5.00024-x
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Elfadadny, A., Ragab, R.F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., et al. (2024) Antimicrobial Resistance of Pseudomonas Aeruginosa: Navigating Clinical Impacts, Current Resistance Trends, and Innovations in Breaking Therapies. Frontiers in Microbiology, 15. &gt;https://doi.org/10.3389/fmicb.2024.1374466
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Aleksandrowicz, A., Carolak, E., Dutkiewicz, A., Błachut, A., Waszczuk, W. and Grzymajlo, K. (2023) Better Together—Salmonella Biofilm-Associated Antibiotic Resistance. Gut Microbes, 15, Article ID: 2229937. &gt;https://doi.org/10.1080/19490976.2023.2229937
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Andino, A. and Hanning, I. (2015) Salmonella enterica: Survival, Colonization, and Virulence Differences among Serovars. The Scientific World Journal, 2015, Article ID: 520179. &gt;https://doi.org/10.1155/2015/520179
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Giannella, R. (1996) Salmonella. In: Baron, S., Ed., Medical Microbiology, 4th Edition, University of Texas Medical Branch at Galveston.
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Robertson, J., Schonfeld, J., Bessonov, K., Bastedo, P. and Nash, J.H.E. (2023) A Global Survey of Salmonella Plasmids and Their Associations with Antimicrobial Resistance. Microbial Genomics, 9, Article ID: 001002. &gt;https://doi.org/10.1099/mgen.0.001002
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lehner, R., Wang, X. and Hunziker, P. (2013) Plasmid Linearization Changes Shape and Efficiency of Transfection Complexes. European Journal of Nanomedicine, 5, 205-212. &gt;https://doi.org/10.1515/ejnm-2013-0028
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bethke, J.H., Ma, H.R., Tsoi, R., Cheng, L., Xiao, M. and You, L. (2022) Vertical and Horizontal Gene Transfer Tradeoffs Direct Plasmid Fitness. Molecular Systems Biology, 19, e11300. &gt;https://doi.org/10.15252/msb.202211300
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mancuso, G., Midiri, A., Gerace, E. and Biondo, C. (2021) Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens, 10, Article 1310. &gt;https://doi.org/10.3390/pathogens10101310
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Marutescu, L.G., Popa, M., Gheorghe-Barbu, I., Barbu, I.C., Rodríguez-Molina, D., Berglund, F., et al. (2023) Wastewater Treatment Plants, an “Escape Gate” for ESCAPE Pathogens. Frontiers in Microbiology, 14, Article 1193907. &gt;https://doi.org/10.3389/fmicb.2023.1193907
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gervasoni, L.F., Peixoto, I.C., Imperador, A.C., De Oliveira, L.B., Correia, L.F., de Oliveira Vieira, K.C., et al. (2023) Relationship between Antibiotic Resistance, Biofilm Formation, Virulence Factors and Source of Origin of Pseudomonas aeruginosa Environmental Isolates with Regard to the Presence of Metallo-β-Lactamase-Encoding Genes. Microbial Pathogenesis, 182, Article ID: 106223. &gt;https://doi.org/10.1016/j.micpath.2023.106223
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shobo, C.O., Amoako, D.G., Allam, M., Ismail, A., Essack, S.Y. and Bester, L.A. (2023) A Genomic Snapshot of Antibiotic-Resistantenterococcus Faecalis within Public Hospital Environments in South Africa. Global Health, 2023, Article ID: 6639983. &gt;https://doi.org/10.1155/2023/6639983
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref31">
    <label>31</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Iweriebor, B., Gaqavu, S., Obi, L., Nwodo, U. and Okoh, A. (2015) Antibiotic Susceptibilities of Enterococcus Species Isolated from Hospital and Domestic Wastewater Effluents in Alice, Eastern Cape Province of South Africa. International Journal of Environmental Research and Public Health, 12, 4231-4246. &gt;https://doi.org/10.3390/ijerph120404231
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref32">
    <label>32</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zhang, R., Yang, S., An, Y., Wang, Y., Lei, Y. and Song, L. (2022) Antibiotics and Antibiotic Resistance Genes in Landfills: A Review. Science of the Total Environment, 806, Article ID: 150647. &gt;https://doi.org/10.1016/j.scitotenv.2021.150647
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref33">
    <label>33</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zainab, S.M., Junaid, M., Xu, N. and Malik, R.N. (2020) Antibiotics and Antibiotic Resistant Genes (ARGs) in Groundwater: A Global Review on Dissemination, Sources, Interactions, Environmental and Human Health Risks. Water Research, 187, Article ID: 116455. &gt;https://doi.org/10.1016/j.watres.2020.116455
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref34">
    <label>34</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Manaia, C.M., Rocha, J., Scaccia, N., Marano, R., Radu, E., Biancullo, F., et al. (2018) Antibiotic Resistance in Wastewater Treatment Plants: Tackling the Black Box. Environment International, 115, 312-324. &gt;https://doi.org/10.1016/j.envint.2018.03.044
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref35">
    <label>35</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kraemer, S.A., Ramachandran, A. and Perron, G.G. (2019) Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy. Microorganisms, 7, Article 180. &gt;https://doi.org/10.3390/microorganisms7060180
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref36">
    <label>36</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wang, J., Xu, S., Zhao, K., Song, G., Zhao, S. and Liu, R. (2023) Risk Control of Antibiotics, Antibiotic Resistance Genes (ARGs) and Antibiotic Resistant Bacteria (ARB) during Sewage Sludge Treatment and Disposal: A Review. Science of the Total Environment, 877, Article ID: 162772. &gt;https://doi.org/10.1016/j.scitotenv.2023.162772
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref37">
    <label>37</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rizzo, L., Manaia, C., Merlin, C., Schwartz, T., Dagot, C., Ploy, M.C., et al. (2013) Urban Wastewater Treatment Plants as Hotspots for Antibiotic Resistant Bacteria and Genes Spread into the Environment: A Review. Science of the Total Environment, 447, 345-360. &gt;https://doi.org/10.1016/j.scitotenv.2013.01.032
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref38">
    <label>38</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Qumsani, A.T. (2023) Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria. Pakistan Journal of Biological Sciences, 26, 131-137. &gt;https://doi.org/10.3923/pjbs.2023.131.137
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref39">
    <label>39</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Karkman, A., Do, T.T., Walsh, F. and Virta, M.P.J. (2018) Antibiotic-Resistance Genes in Waste Water. Trends in Microbiology, 26, 220-228. &gt;https://doi.org/10.1016/j.tim.2017.09.005
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref40">
    <label>40</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jochum, J.M., Redweik, G.A.J., Ott, L.C. and Mellata, M. (2021) Bacteria Broadly-Resistant to Last Resort Antibiotics Detected in Commercial Chicken Farms. Microorganisms, 9, Article 141. &gt;https://doi.org/10.3390/microorganisms9010141
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref41">
    <label>41</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tuvo, B., Scarpaci, M., Bracaloni, S., Esposito, E., Costa, A.L., Ioppolo, M., et al. (2023) Microplastics and Antibiotic Resistance: The Magnitude of the Problem and the Emerging Role of Hospital Wastewater. International Journal of Environmental Research and Public Health, 20, Article 5868. &gt;https://doi.org/10.3390/ijerph20105868
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref42">
    <label>42</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dionisio, F., Domingues, C.P.F., Rebelo, J.S., Monteiro, F. and Nogueira, T. (2023) The Impact of Non-Pathogenic Bacteria on the Spread of Virulence and Resistance Genes. International Journal of Molecular Sciences, 24, Article 1967. &gt;https://doi.org/10.3390/ijms24031967
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref43">
    <label>43</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Martínez, J.L. (2012) Bottlenecks in the Transferability of Antibiotic Resistance from Natural Ecosystems to Human Bacterial Pathogens. Frontiers in Microbiology, 2, Article 265. &gt;https://doi.org/10.3389/fmicb.2011.00265
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref44">
    <label>44</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Keelara, S. and Thakur, S. (2014) Dissemination of Plasmid-Encoded AmpC β-Lactamases in Antimicrobial Resistant Salmonella Serotypes Originating from Humans, Pigs and the Swine Environment. Veterinary Microbiology, 173, 76-83. &gt;https://doi.org/10.1016/j.vetmic.2014.07.018
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref45">
    <label>45</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kempf, A.J., Hulsebus, H.J. and Akbar, S. (2016) Multiple Plasmids Contribute to Antibiotic Resistance and Macrophage Survival in Vitro in CMY2-BearingSalmonella enterica. Foodborne Pathogens and Disease, 13, 398-404. &gt;https://doi.org/10.1089/fpd.2015.2067
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref46">
    <label>46</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Castañeda-Barba, S., Top, E.M. and Stalder, T. (2023) Plasmids, a Molecular Cornerstone of Antimicrobial Resistance in the One Health Era. Nature Reviews Microbiology, 22, 18-32. &gt;https://doi.org/10.1038/s41579-023-00926-x
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref47">
    <label>47</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, L. and Zhang, T. (2023) Plasmid-Mediated Antibiotic Resistance Gene Transfer under Environmental Stresses: Insights from Laboratory-Based Studies. Science of the Total Environment, 887, Article ID: 163870. &gt;https://doi.org/10.1016/j.scitotenv.2023.163870
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref48">
    <label>48</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Larsson, D.G.J., Andremont, A., Bengtsson-Palme, J., Brandt, K.K., de Roda Husman, A.M., Fagerstedt, P., et al. (2018) Critical Knowledge Gaps and Research Needs Related to the Environmental Dimensions of Antibiotic Resistance. Environment International, 117, 132-138. &gt;https://doi.org/10.1016/j.envint.2018.04.041
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref49">
    <label>49</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ramanan Laxminarayan, T.V. (2015) The Economic Costs of Withdrawing Anti-Microbial Growth Promoters from the Livestock Sector. OECD Food, Agriculture and Fisheries Papers, 42.
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref50">
    <label>50</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Centers for Disease Control and Prevention (2023) U.S. Antibiotic Resistance (AR) Programs and Activities. Centers for Disease Control and Prevention. &gt;https://www.cdc.gov/antimicrobial-resistance/programs/AR-actions-events.html 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref51">
    <label>51</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     CDC (2019) Antibiotic Resistance Threats in the United States. U.S. Department of Health and Human Services, 150.
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref52">
    <label>52</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     U.S. Department of Health and Human Services (2025) Antimicrobial Resistance. U.S. Department of Health and Human Services. &gt;https://www.hhs.gov/about/agencies/oga/global-health-security/antimicrobial-resistance/index.html 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref53">
    <label>53</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Centers for Disease Control and Prevention (2021) The AMR Challenge. Centers for Disease Control and Prevention. &gt;https://archive.cdc.gov/www_cdc_gov/drugresistance/us-activities/amr-challenge.html 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref54">
    <label>54</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Antimicrobial Stewardship (2022) Indiana Department of Health. &gt;https://www.in.gov/health/idepd/healthcare-associated-infections-and-antimicrobial-resistance-epidemiology/antimicrobial-stewardship/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref55">
    <label>55</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Indiana Department of Health: Antimicrobial Resistance. Indiana Department of Health. &gt;https://www.in.gov/health/idepd/healthcare-associated-infections-and-antimicrobial-resistance-epidemiology/antimicrobial-resistance/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref56">
    <label>56</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Center for Disease Dynamics, Economics&amp;Policy (CDDEP) (2015) The State of the World’s Antibiotics, 2015. &gt;https://cddep.org/publications/state_worlds_antibiotics_2015/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref57">
    <label>57</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gandra, S., Kotwani, A. and Laxminarayan, R. (2017) Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016. WHO South-East Asia Journal of Public Health, 9, 107-115. 
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref58">
    <label>58</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Azuma, T., Usui, M. and Hayashi, T. (2022) Inactivation of Antibiotic-Resistant Bacteria in Wastewater by Ozone-Based Advanced Water Treatment Processes. Antibiotics, 11, Article 210. &gt;https://doi.org/10.3390/antibiotics11020210
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref59">
    <label>59</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Reisoglu, Ş. and Aydin, S. (2023) Bacteriophages as a Promising Approach for the Biocontrol of Antibiotic Resistant Pathogens and the Reconstruction of Microbial Interaction Networks in Wastewater Treatment Systems: A Review. Science of the Total Environment, 890, Article ID: 164291. &gt;https://doi.org/10.1016/j.scitotenv.2023.164291
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref60">
    <label>60</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Iakovides, I.C., Michael-Kordatou, I., Moreira, N.F.F., Ribeiro, A.R., Fernandes, T., Pereira, M.F.R., et al. (2019) Continuous Ozonation of Urban Wastewater: Removal of Antibiotics, Antibiotic-Resistant Escherichia Coli and Antibiotic Resistance Genes and Phytotoxicity. Water Research, 159, 333-347. &gt;https://doi.org/10.1016/j.watres.2019.05.025
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref61">
    <label>61</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Le, T., Ng, C., Tran, N.H., Chen, H. and Gin, K.Y. (2018) Removal of Antibiotic Residues, Antibiotic Resistant Bacteria and Antibiotic Resistance Genes in Municipal Wastewater by Membrane Bioreactor Systems. Water Research, 145, 498-508. &gt;https://doi.org/10.1016/j.watres.2018.08.060
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref62">
    <label>62</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Price, E.D.J., Dassanayake, R.P. and Bearson, S.M.D. (2023) Increasing Antimicrobial Susceptibility of MDR Salmonella with the Efflux Pump Inhibitor 1-(1-Naphthylmethyl)-Piperazine. Biochemical and Biophysical Research Communications, 668, 49-54. &gt;https://doi.org/10.1016/j.bbrc.2023.05.035
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref63">
    <label>63</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bengtsson-Palme, J., Abramova, A., Berendonk, T.U., Coelho, L.P., Forslund, S.K., Gschwind, R., et al. (2023) Towards Monitoring of Antimicrobial Resistance in the Environment: For What Reasons, How to Implement It, and What Are the Data Needs? Environment International, 178, Article ID: 108089. &gt;https://doi.org/10.1016/j.envint.2023.108089
    </mixed-citation>
   </ref>
   <ref id="scirp.146045-ref64">
    <label>64</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cristina Zarama: Antimicrobial Resistance&amp;Multidrug Resistant Salmonella. University of Minnesota. &gt;https://cahfs.umn.edu/antimicrobial-resistance-multidrug-resistant-salmonella
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>